Extension Study to Assess Long Term Safety, Tolerability, and Efficacy of Valsartan and Enalapril Combined and Alone in Children With Hypertension

NCT00446511 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Valsartan
DRUG: Enalapril
DRUG: placebo matched to enalapril
DRUG: placebo matched to valsartan

Sponsor

Novartis Pharmaceuticals